During the past decade, Taunton and Somerset Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taunton and Somerset Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Abbott" with 2 trials sponsored, "Aberdeen Royal Infirmary" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taunton and Somerset Hospital" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Lymphoma Trials Office" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "Nordic Lymphoma Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Taunton and Somerset Hospital" are "Lymphoma" (3 trials), "Ovarian Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Taunton and Somerset Hospital" in a lesser frequency.

Most popular intervention types in "Taunton and Somerset Hospital" are "Drug" (12 trials), "Procedure" (7 trials), "Other" (6 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "cyclophosphamide" (3 trials), "fludarabine phosphate" (3 trials), "quality-of-life assessment" (3 trials) and "Atrasentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Taunton and Somerset Hospital" are 9 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Taunton and Somerset Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Taunton and Somerset Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taunton and Somerset Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".